Conversion of human bone marrow-derived mesenchymal stem cells into tendon progenitor cells by ectopic expression of scleraxis.
about
Therapeutic Roles of Tendon Stem/Progenitor Cells in TendinopathyTenogenic modulating insider factor: Systematic assessment on the functions of tenomodulin geneTendon development and musculoskeletal assembly: emerging roles for the extracellular matrixMolecular regulation of tendon cell fate during developmentGrowth and Development Symposium: Stem cell therapy in equine tendon injuryMarkers for the identification of tendon-derived stem cells in vitro and tendon stem cells in situ - update and future developmentGene therapy approaches to regenerating the musculoskeletal systemTranscription factor EGR1 directs tendon differentiation and promotes tendon repair.Glutamate signaling through the NMDA receptor reduces the expression of scleraxis in plantaris tendon derived cells.Three-dimensional culture and transforming growth factor beta3 synergistically promote tenogenic differentiation of equine embryo-derived stem cellsRegulation of Tenomodulin Expression Via Wnt/β-catenin Signaling in Equine Bone Marrow-derived Mesenchymal Stem Cells.Loss of tenomodulin results in reduced self-renewal and augmented senescence of tendon stem/progenitor cellsProbing the interaction forces of prostate cancer cells with collagen I and bone marrow derived stem cells on the single cell level.Transcription factor Mohawk controls tenogenic differentiation of bone marrow mesenchymal stem cells in vitro and in vivo.Cellular and molecular maturation in fetal and adult ovine calcaneal tendons.Scx-transduced tendon-derived stem cells (tdscs) promoted better tendon repair compared to mock-transduced cells in a rat patellar tendon window injury model.Mechanical stimulation of human tendon stem/progenitor cells results in upregulation of matrix proteins, integrins and MMPs, and activation of p38 and ERK1/2 kinases.SRY induced TCF21 genome-wide targets and cascade of bHLH factors during Sertoli cell differentiation and male sex determination in ratsBiologics for tendon repairForce and scleraxis synergistically promote the commitment of human ES cells derived MSCs to tenocytesMesenchymal stromal cells from bone marrow treated with bovine tendon extract acquire the phenotype of mature tenocytesA bioreactor system for in vitro tendon differentiation and tendon tissue engineering.Dental pulp stem cells express tendon markers under mechanical loading and are a potential cell source for tissue engineering of tendon-like tissue.Systematic approaches to dissect biological processes in stem cells by image-based screening.Common threads in cardiac fibrosis, infarct scar formation, and wound healing.Tendon stem cells: experimental and clinical perspectives in tendon and tendon-bone junction repair.Canine mesenchymal stem cells: state of the art, perspectives as therapy for dogs and as a model for man.Crucial transcription factors in tendon development and differentiation: their potential for tendon regeneration.A tale of 2 tissues: the overlapping role of scleraxis in tendons and the heart.Growth factor delivery vehicles for tendon injuries: Mesenchymal stem cells and Platelet Rich Plasma.Physical regulation of stem cells differentiation into teno-lineage: current strategies and future direction.Uncovering the cellular and molecular changes in tendon stem/progenitor cells attributed to tendon aging and degeneration.Tendon development and diseases.Stem Cells in Skeletal Tissue Engineering: Technologies and Models.Enhanced tenogenic differentiation and tendon-like tissue formation by tenomodulin overexpression in murine mesenchymal stem cells.Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells.Mechanical Control of Myotendinous Junction Formation and Tendon Differentiation during Development.Molecular characterization and function of tenomodulin, a marker of tendons and ligaments that integrate musculoskeletal components.Retinoic acid receptor signaling preserves tendon stem cell characteristics and prevents spontaneous differentiation in vitrox.Development of antisense oligonucleotide (ASO) technology against Tgf-β signaling to prevent scarring during flexor tendon repair.
P2860
Q26748484-B96D98FE-E3C9-45FB-899F-2A244EF64B93Q26748847-0CA4933E-080C-4989-BF95-E21FEBC27C3FQ26775671-62DDC4F5-3F31-42AE-A7D8-FC6BDEE18029Q26829280-FCA42D63-BCEB-45E7-B77C-C7BAA16F1158Q27001066-F1B951E3-C05B-4123-8A03-52F00E898D2DQ27023319-7CE01492-8193-4CB8-8BC3-7C16F9D95F21Q28083399-0E69D3CE-62C2-41E1-B2B6-44025A2AE226Q33570335-EE067448-0465-436D-8C60-AB2158A4E62EQ33730882-EA0B63DF-9840-4293-A643-75C06850C244Q34331010-23BA25A5-466A-4704-B9E7-DCFEAEC99A02Q34420276-B20AC9A5-606C-470A-9450-E21150A0F047Q34445255-27FF2B13-E069-4641-8B9D-4FACAD602374Q34614433-1E106B1E-E6D2-43C5-9B99-DFFB5BAE9DBCQ34960261-29220A68-CAA9-42D4-B131-E71E47B1F16FQ35006322-FFB0AB01-4418-4B5E-91A7-2138A97A166AQ35169389-47355B0E-48BB-4E8B-8542-8F668E512847Q35603672-871C956C-8F64-4D18-983F-915401229DCBQ35618374-6A135C90-7EA2-4500-ADC3-987A87110FF2Q35900746-3A23861A-E5B6-4A27-AB38-B5C12D6694E0Q36466095-FB145D67-B72D-492C-BBE9-813DB0AF7D9AQ36620470-1FEDE1F7-D7EA-468C-A8D5-E16F212AB4D5Q37397659-D7485A96-D62C-48B3-AB7B-CABEC9B9FDDBQ37516363-43D5399A-A497-4AD0-8CA7-666E0906D8D9Q38015282-4B2A0299-6398-4C77-A649-D2429C9BB33CQ38056814-C7D74822-CB74-46D4-8DEE-F19BF1D14499Q38112144-C49A397F-25A9-437F-8E6B-57861F6FAFE7Q38176931-B8B10D3D-F932-4537-B663-47959C288155Q38202522-DE35B490-ED3E-4058-A037-89CD6BA664C0Q38235977-A9BB63D3-992B-4AB0-A12C-3D2D3272057FQ38285672-5A147A90-967A-4377-96F0-C5F8429A3637Q38304022-6B55C94F-AFB6-4AA4-A1CD-AAF10B91C2E5Q38488406-DBF21757-CD6D-40BC-BF19-A08673002A8BQ38563509-DFBE0AB9-7328-461F-A17A-635D9D37E268Q38595986-4651C7F6-0C61-4094-ACF2-85CBD18B5323Q38776650-603A32EA-7F32-47BE-B68C-0547F4742684Q39190753-3111F616-58BF-4A22-B354-12FAA44DEA23Q39225632-588FFD24-8C77-4930-865D-27CD7724D2EEQ39241879-4073467D-5E2F-43B9-BD60-6DE185E5A7C5Q39322525-2DB2FDE0-EB64-49A6-8776-6BF3572801F3Q40170614-F851F356-27E6-495E-9B36-326CAC545005
P2860
Conversion of human bone marrow-derived mesenchymal stem cells into tendon progenitor cells by ectopic expression of scleraxis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Conversion of human bone marro ...... topic expression of scleraxis.
@ast
Conversion of human bone marro ...... topic expression of scleraxis.
@en
Conversion of human bone marro ...... topic expression of scleraxis.
@nl
type
label
Conversion of human bone marro ...... topic expression of scleraxis.
@ast
Conversion of human bone marro ...... topic expression of scleraxis.
@en
Conversion of human bone marro ...... topic expression of scleraxis.
@nl
prefLabel
Conversion of human bone marro ...... topic expression of scleraxis.
@ast
Conversion of human bone marro ...... topic expression of scleraxis.
@en
Conversion of human bone marro ...... topic expression of scleraxis.
@nl
P2093
P2860
P50
P356
P1476
Conversion of human bone marro ...... topic expression of scleraxis.
@en
P2093
Chisa Shukunami
Julia Kohler
Markus Prägert
Paolo Alberton
P2860
P304
P356
10.1089/SCD.2011.0150
P577
2011-10-11T00:00:00Z